Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-04-11 00:28 | 2018-04-06 | AVEO | N/A | Growth Equity Opportunities IV, LLC | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:29 | 2018-04-06 | AVEO | N/A | BASKETT FOREST | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:31 | 2018-04-06 | AVEO | N/A | SANDELL SCOTT D | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:30 | 2018-04-06 | AVEO | N/A | MAKOWER JOSHUA | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:30 | 2018-04-06 | AVEO | N/A | MOTT DAVID M | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:23 | 2018-04-04 | ICTSF | ICTS INTERNATIONAL N V | Atzmon Menachem | Director | Services-Business Services, NEC | BUY | $0.66 | 1,850,000 | $1,221,000 | 4,850,000 | +61.7% |
| 2018-04-11 00:29 | 2018-04-06 | AVEO | N/A | BARRIS PETER J | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-09 15:49 | 2018-04-05 | FEIM | FREQUENCY ELECTRONICS INC | Edenbrook Capital, LLC | Director, 10% owner | Instruments For Meas & Testing of Electricity & Elec Signals | BUY | $9.00 | 150,000 | $1,350,000 | 1,143,101 | +15.1% |
| 2018-04-09 15:31 | 2018-04-05 | ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | Deer Park Road Management Company, LP | 10% owner | Services-Miscellaneous Business Services | BUY | $25.93 | 111,516 | $2,891,298 | 3,056,643 | +3.8% |
| 2018-04-10 00:20 | 2018-04-09 | ICPT | N/A | Genextra S.p.A. | 10% owner | Other | BUY | $64.00 | 390,625 | $25,000,000 | 6,845,578 | +6.1% |
| 2018-04-10 00:19 | 2018-04-09 | ICPT | N/A | Micheli Francesco | 10% owner | Other | BUY | $64.00 | 390,625 | $25,000,000 | 6,845,578 | +6.1% |
| 2018-04-09 20:19 | 2018-04-05 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $36.58 | 50,000 | $1,828,845 | 5,903,799 | +0.9% |
| 2018-04-09 13:51 | 2018-04-05 | CTL | Lumen Technologies, Inc. | Temasek Holdings (Private) Ltd | 10% owner | Telephone Communications (No Radiotelephone) | BUY | $17.41 | 5,036,884 | $87,700,209 | 123,201,207 | +4.3% |
| 2018-04-06 20:54 | 2018-04-04 | WINT | WINDTREE THERAPEUTICS INC /DE/ | Lee's Pharmaceutical Holdings Ltd | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $4.80 | 541,667 | $2,600,002 | 2,853,271 | +23.4% |
| 2018-04-07 00:29 | 2017-12-27 | AIRT | Air T, Inc. | Swenson Nicholas John | Director, Officer, 10% owner - CEO | Air Courier Services | BUY | $24.74 | 52,742 | $1,304,879 | 52,742 | +100.0% |
| 2018-04-07 00:45 | 2018-04-04 | ANGI | Angi Inc. | Luxor Capital Group, LP | 10% owner | Services-Advertising | BUY | $13.39 | 493,500 | $6,607,422 | 4,042,598 | +13.9% |
| 2018-04-05 19:27 | 2018-04-03 | UMRX | Cogent Biosciences, Inc. | FMR LLC | Other | Pharmaceutical Preparations | BUY | $12.00 | 94,052 | $1,128,624 | 452,115 | +26.3% |
| 2018-04-05 13:02 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | VIKING GLOBAL INVESTORS LP | 10% owner | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-05 19:04 | 2018-04-03 | CTL | Lumen Technologies, Inc. | Temasek Holdings (Private) Ltd | 10% owner | Telephone Communications (No Radiotelephone) | BUY | $16.72 | 7,620,118 | $127,373,320 | 118,164,323 | +6.9% |
| 2018-04-04 23:17 | 2018-04-02 | TIF | N/A | Trapani Francesco | Director | Other | BUY | $94.66 | 35,000 | $3,313,254 | 445,000 | +8.5% |
| 2018-04-04 13:48 | 2018-04-03 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $134.32 | 20,000 | $2,686,476 | 10,650,193 | +0.2% |
| 2018-04-04 23:59 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | SVF Investments (UK) Ltd | 10% owner | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-05 00:00 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | Lo Andrew | 10% owner | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-04 23:24 | 2018-04-02 | FIXX | Q32 Bio Inc. | Vida Ventures, LLC | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 375,000 | $6,000,000 | 770,845 | +94.7% |
| 2018-04-05 02:18 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | Dexxon Holdings Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-04 23:52 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | Roivant Sciences Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-04 23:24 | 2018-04-02 | FIXX | Q32 Bio Inc. | Rock Springs Capital Management LP | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 250,000 | $4,000,000 | 645,845 | +63.2% |
| 2018-04-04 19:56 | 2018-04-02 | DDR | SITE Centers Corp. | Otto Alexander | Director, 10% owner | Real Estate Investment Trusts | BUY | $7.31 | 711,616 | $5,202,482 | 52,860,079 | +1.4% |
| 2018-04-04 20:21 | 2018-02-28 | AUSI | AURA SYSTEMS INC | Breslow Warren | 10% owner | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $1.62 | 7,447,178 | $12,064,428 | 7,682,751 | +3,161.3% |
| 2018-04-04 23:51 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | Machado Patrick | 10% owner | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-04 23:29 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | QVT Associates GP LLC | Director, 10% owner, Other | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-05 04:58 | 2018-04-02 | MYOV | Myovant Sciences Ltd. | VIKING GLOBAL PERFORMANCE LLC | 10% owner | Pharmaceutical Preparations | BUY | $20.27 | 1,110,015 | $22,500,004 | 38,341,357 | +3.0% |
| 2018-04-05 04:25 | 2018-04-02 | AKAO | N/A | DUGGAN ROBERT W | 10% owner | Other | BUY | $12.46 | 91,461 | $1,139,421 | 6,482,569 | +1.4% |
| 2018-04-04 20:33 | 2018-04-02 | FIXX | Q32 Bio Inc. | Temasek Holdings (Private) Ltd | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 625,000 | $10,000,000 | 3,220,293 | +24.1% |
| 2018-04-05 03:56 | 2018-04-02 | FIXX | Q32 Bio Inc. | Flynn James E | Director, 10% owner, Other | Pharmaceutical Preparations | BUY | $16.00 | 1,250,000 | $20,000,000 | 625,000 | +100.0% |
| 2018-04-03 20:02 | 2018-04-02 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $134.01 | 55,596 | $7,450,476 | 10,630,193 | +0.5% |
| 2018-04-04 03:42 | 2018-01-12 | AMMA | SCWorx Corp. | Gamberale Joseph | Director | Services-Computer Processing & Data Preparation | BUY | $25,000.00 | 25,000 | $625,000,000 | 621,193 | +4.2% |
| 2018-04-04 00:11 | 2018-04-03 | UMRX | Cogent Biosciences, Inc. | Atlas Venture Fund IX, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $12.00 | 94,052 | $1,128,624 | 3,361,535 | +2.9% |
| 2018-04-03 23:30 | 2018-04-03 | UMRX | Cogent Biosciences, Inc. | Ratcliffe Liam | Director | Pharmaceutical Preparations | BUY | $12.00 | 550,000 | $6,600,000 | 897,773 | +158.1% |
| 2018-04-04 00:07 | 2018-04-03 | UMRX | Cogent Biosciences, Inc. | Booth Bruce | Director | Pharmaceutical Preparations | BUY | $12.00 | 94,052 | $1,128,624 | 3,361,535 | +2.9% |
| 2018-04-03 19:01 | 2018-03-30 | PBIB | N/A | WYCOFF W KIRK | Director | Other | BUY | $13.00 | 150,000 | $1,950,000 | 159,255 | +1,620.7% |
| 2018-04-03 00:13 | 2018-03-29 | CATM | N/A | Hudson Executive Capital LP | 10% owner | Other | BUY | $22.47 | 63,100 | $1,417,857 | 6,387,830 | +1.0% |
| 2018-04-02 16:57 | 2018-03-29 | DDR | SITE Centers Corp. | Otto Alexander | Director, 10% owner | Real Estate Investment Trusts | BUY | $7.34 | 393,568 | $2,888,081 | 52,148,463 | +0.8% |
| 2018-04-02 23:20 | 2018-03-29 | ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | Deer Park Road Management Company, LP | 10% owner | Services-Miscellaneous Business Services | BUY | $26.18 | 101,359 | $2,653,528 | 2,945,127 | +3.6% |
| 2018-04-02 20:02 | 2018-03-28 | PSDV | EyePoint, Inc. | EW Healthcare Partners, L.P. | 10% owner | Laboratory Analytical Instruments | BUY | $1.10 | 8,606,324 | $9,466,956 | 8,606,324 | +100.0% |
| 2018-04-02 23:01 | 2018-03-29 | HRTX | HERON THERAPEUTICS, INC. /DE/ | TANG KEVIN C | Director, 10% owner | Pharmaceutical Preparations | BUY | $26.00 | 192,308 | $5,000,008 | 8,525,215 | +2.3% |
| 2018-03-30 23:28 | 2018-03-28 | OCX | Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $1.26 | 3,968,254 | $5,000,000 | 7,564,934 | +110.3% |
| 2018-03-29 21:07 | 2017-11-28 | BOXL | Boxlight Corp | Kuo Wei-Wu | 10% owner | Services-Educational Services | BUY | $7.00 | 286,442 | $2,005,094 | 2,933,722 | +10.8% |
| 2018-03-29 18:47 | 2018-03-28 | DDR | SITE Centers Corp. | Otto Alexander | Director, 10% owner | Real Estate Investment Trusts | BUY | $7.24 | 377,331 | $2,731,424 | 51,754,895 | +0.7% |
| 2018-03-30 00:45 | 2018-03-28 | APPN | Appian Corporation | Abdiel Capital Management, LLC | 10% owner | Services-Prepackaged Software | BUY | $25.74 | 100,000 | $2,574,000 | 5,509,464 | +1.8% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.